门静脉血栓介入治疗研究进展

doi:10.3969/j.issn.1672-5069.2019.06.003

Abstract

Bao Yingjun, Ren Weixin.. Interventional therapy for patients with portal vein thrombosis[J]. Journal of Practical Hepatology, 2019, 22(6): 768-769.

[1] Chawla YK,Bodh V.Portal vein thrombosis. J Clin Exp Hepatol, 2015,32(5):22-40.
[2] Tripodi A,Anstee QM,Sogaard KK,et al.Hypercoagulability in cirrhosis:causes and consequences. J Thromb Haemost,2011,9:1713-1723.
[3] Okuda K,Ohnishi K,Kimura K,et al.Incidence of portal vein thrombosis in liver cirrhosis. An angiographic study in 708 patients. Gastroenterology,1985,89:279-286.
[4] Amitrano L,Guardascione MA,Brancaccio V,et al.Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis. J Hepatol, 2004,40:736-741.
[5] Tsochatzis EA,Senzolo M,Germani G,et al.Portal vein thrombosis in cirrhosis. Aliment Pharmacol Ther,2010,31:366-374.
[6] Mantaka A,Augoustaki A,Kouroumalis EA,et al.Portal vein thrombosis in cirrhosis:diagnosis,natural history,and therapeutic challenges. Ann Gastroenterol,2018,31: 315-329.
[7] Loffredo L,Pastori D,Farcomeni A,et al.Effects of anticoagulants in patients with cirrhosis and portal vein thrombosis:a systematic review and meta-analysis. Gastroenterology,2017,153:480-487.
[8] von Kockritz1 L,de Gottardi1 A,Trebicka J,et al. Portal vein thrombosis in patients with cirrhosis. Gastroenterol Rep,2017,5(2):148-156.
[9] de Franchis R,Baveno VI Faculty. Expanding consensus in portal hypertension:report of the Baveno VI Consensus Workshop: stratifying risk and individualizing care for portal hypertension. J Hepatol,2015,63:743-752.
[10] Rossle M.TIPS: 25 years later. J Hepatol,2013,59:1081-1093.
[11] Han G,Qi X,He C,et al.Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with symptomatic portal hypertension in liver cirrhosis. J Hepatol, 2011,54:78-88.
[12] Luca A,Miraglia R,Caruso S, et al.Short- and long-term effects of the transjugular intrahepatic portosystemic shunt on portal vein thrombosis in patients with cirrhosis. Gut, 2011,60:846-852.
[13] Primignani M,Tosetti G, La Mura V.Therapeutic and clinical aspects of portal vein thrombosis in patients with cirrhosis. World J Hepatol, 2015,7:2906-2912.
[14] Perarnau JM, Baju A,D’alteroche L,et al.Feasibility and long-term evolution of TIPS in cirrhotic patients with portal thrombosis. Eur J Gastroenterol Hepatol,2010,22:1093-1098.
[15] 刘凤永,王茂强,王志强,等.介入治疗门静脉-肠系膜上静脉广泛血栓形成1例.中华肝胆外科杂志,2013,9(10):598-610.
[16] Francoz C,Valla D,Durand F.Portal vein thrombosis,cirrhosis,and liver transplantation. J Hepatol,2012,57:203-212.

Interventional therapy for patients with portal vein thrombosis

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Chen Shuai, Yang Changqing.. Pathogenesis and risk factors of portal vein thrombosis [J]. Journal of Practical Hepatology, 2019, 22(6): 761-764.
[2]	Zhuang Ying, Lin Zhihui.. Clinical manifestations and diagnosis of portal vein thrombosis [J]. Journal of Practical Hepatology, 2019, 22(6): 765-767.
[3]	Xu Qilin, Hao Shaohuan, Ran Bo. Risk factors of portal vein thrombosis after splenectomy in patients with liver cirrhosis and portal hypertension [J]. Journal of Practical Hepatology, 2019, 22(5): 708-711.
[4]	Huang Zhiyin, Li Jing. Splenectomy in patients with liver cirrhosis：the pros and cons [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 459-461.
[5]	Liu Yanjun, Li Guangming. Prophylaxis and management of patients with portal vein thrombosis complicting liver cirrhosis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 605-608.
[6]	Xiao Ke, Pan Zhihua, Tu Bo. Predictive value of preoperative CT/MRI indicators for portal vein thrombosis in patients with liver cirrhosis after splenectomy [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(3): 417-420.
[7]	Zhao Xiaofei, Lin Dongdong, Li Ning, Zang Yunjin, Guo Qingliang, Wu Juanshan. Application of warfarin in dealing with portal vein thrombosis in patients with liver cirrhosis after splenectomy and devascularization [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 240-243.
[8]	Qiu Ting, Jin Yan, Lyu Yifei, et al.. Logistic regression analysis on the risk factors of portal vein thrombosis in patients with liver cirrhosis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(6): 916-919.
[9]	Li Xiangwen, Tu Mingli Department of Surgery, Third Hospital， Yangxin County 435200， Hebei Province. Clinical study of low molecular weight heparin in early prevention of portal vein thrombosis in patients with liver cirrhosis after laparoscopic splenectomy with esophagogastric devascularization [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(2): 179-182.
[10]	Lu Shenxin，Chen Shiyao.. Anticoagulant therapy in patients with liver cirrhosis complicated by portal vein thrombosis:evidence-based medicine [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2016, 19(5): 624-628.
[11]	Yang Jinhui, Tang Yingmei. Evaluation of interventional therapy for patients with hepatocellular carcinoma [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2015, 18(3): 230-232.
[12]	Li Ling, Chen Shiyao. Risk factors of portal vein thrombosis in cirrhotic patients from the view of Virchow’s triad [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2015, 18(3): 325-328.
[13]	Liu Hui, Chen dongfeng. Improvement of embolic materials in vascular inteventional therapy of patients with primary liver cancer [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2015, 18(3): 333-336.
[14]	Zang Lina, Liu Xiaofeng. Progress in portal vein thrombosis in patients with liver cirrhosis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2014, 17(4): 429-432.
[15]	Jiang Jiali, Zhan Yutao, Li Li. The plasma D-dimer levels and their clinical significance in liver cirrhosis patients with portal vein thrombosis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2012, 15(1): 26-28.